Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
COL MIG-301 Study Group
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
213
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
lasmiditan
100%
Migraine Disorders
50%
Odds Ratio
16%
Confidence Intervals
14%
Placebos
12%
Headache
10%
Hyperacusis
9%
Therapeutics
8%
Photophobia
7%
Pain-Free
7%
Diaries
6%
Nausea
5%
Safety
3%
Pain
3%